Applied Clinical Trial - Outsourcing: China Taken Center Stage

Author:

Adam Sherlock is Director, Regulatory Solutions Group at CSC Life Sciences

As regulatory outsourcing to China gathers momentum—with more and more companies selecting partners in the country and establishing offices there—any existing concerns and discrepancies will lessen. Nonetheless, as in any partnership or outsourcing relationship, companies must do their due diligence and learn how to conduct themselves and do business in the Chinese market.

The achievement of success in regulatory outsourcing is not related just to country but is the responsibility of the companies involved. A company needs to be aware of its vendors’ knowledge and capabilities with regard to how they manage their outsource operations and the systems and culture they put in place, Hasler says. “The issue of country matters in ensuring it has a culture that is service focused,” he says. “And China, much like the rest of Southeast Asia, has that service focus and desire to deliver." Read full article (PDF, 279 KB)